Related Experiment Video
Updated: Feb 10, 2026

A "Patient-Like" Orthotopic Syngeneic Mouse Model of Hepatocellular Carcinoma Metastasis
Published on: October 24, 2015
ClC-3 chloride channel protein induces G1 arrest in hepatocellular carcinoma Hep3B cells
Rui Wang1, Bijun Kang2, Rendong Hu2
1Beijing Key Laboratory of Magnetic Resonance Imaging Technology, Beijing 100191, P.R. China.
Abstract:
ClC-3 is a type of chloride channel that has multiple functions in tumorigenesis and tumor growth, and can be blocked by DIDS (4,4'-diisothiocyanostilbene-2,2'-disulfonic acid). In the present study, we found that DIDS inhibited the proliferation of Hep3B hepatocellular carcinoma (HCC) cells in a concentration-dependent manner. More in-depth research demonstrated that DIDS downregulated the protein expression levels of cyclin D1 and cyclin E, which are key proteins of the G1 phase. Additionally, we found that ClC-3 siRNA transfection induced G1 arrest in the Hep3B cells, confirming that ClC-3 is involved in the DIDS-induced inhibition of Hep3B cells. Moreover, the level of α-fetoprotein (AFP), a negative prognostic indicator of HCC, was decreased after treatment with DIDS and ClC-3 siRNA. In conclusion, we demonstrated that ClC-3 can arrest the cell cycle at the G1 phase to inhibit cell proliferation, suggesting that ClC-3 has the potential to be a novel target for HCC therapy and potentially improve the prognosis of HCC patients.
Insights
The chloride channel ClC-3 plays a role in hepatocellular carcinoma (HCC) growth. Blocking ClC-3 with DIDS inhibits cancer cell proliferation and may offer a new therapeutic target for HCC.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Chloride channel 3 (ClC-3) is implicated in tumor progression.
- Hepatocellular carcinoma (HCC) is a significant global health concern.
- Targeting specific cellular pathways offers potential therapeutic strategies for HCC.
Purpose of the Study:
- To investigate the role of ClC-3 in HCC cell proliferation.
- To determine the effect of DIDS (4,4'-diisothiocyanostilbene-2,2'-disulfonic acid) on Hep3B HCC cells.
- To explore ClC-3 as a potential therapeutic target for HCC.
Main Methods:
- Hep3B HCC cells were treated with varying concentrations of DIDS.
- Western blotting was used to assess protein expression levels of cyclin D1 and cyclin E.
- ClC-3 gene silencing was achieved using siRNA transfection.
- α-fetoprotein (AFP) levels were measured post-treatment.
Main Results:
- DIDS inhibited Hep3B cell proliferation in a dose-dependent manner.
- DIDS treatment and ClC-3 siRNA transfection led to downregulation of cyclin D1 and cyclin E, inducing G1 phase arrest.
- ClC-3 siRNA confirmed its involvement in DIDS-mediated inhibition.
- Both DIDS and ClC-3 siRNA reduced α-fetoprotein (AFP) levels.
Conclusions:
- ClC-3 facilitates HCC cell proliferation by regulating the G1 cell cycle phase.
- Inhibition of ClC-3 can induce cell cycle arrest and reduce HCC progression.
- ClC-3 represents a promising novel therapeutic target for hepatocellular carcinoma.
Related Concept Videos
G-Protein Gated Ion Channels
Sensory...
Ion Channels
Ion channels are specialized integral membrane proteins on the plasma membrane that allow...
Electrochemical Gradient and Channel Proteins: An Overview
The electrical gradient: The electrical gradient across cell membranes refers to the difference in electric charge between the inside and outside of a cell. This difference drives the movement of ions towards or away from the cells. For instance, if the inside of the cell is more negatively charged relative to...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Roles of Electrolytes: Chloride and Bicarbonate
Conditions such as hypochloremia can arise from insufficient chloride reabsorption by the kidneys, often compounded by extended bouts of diarrhea, vomiting,...
Carboxylic Acids to Acid Chlorides

